---
schema_version: "secwatch.filing_event.v1"
accession: "0001860742-26-000006"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:09:52.010514+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb Q4 rev $1.405B (+10%), net loss $58M; guides FY2026 rev $5.375B-$5.475B

## Summary
- Q4 revenue $1.405B (+10% reported, +7% constant currency); FY revenue $5.101B (+6% reported, +5% constant currency).
- Q4 GAAP net loss $58M (vs $3M loss in Q4 2024); FY net loss $360M (vs $317M).
- Q4 adjusted EBITDA $326M (+$67M YoY); adjusted EPS $0.32 (vs $0.25). FY adjusted EBITDA $858M; adjusted EPS $0.43.
- Segment: Vision Care $778M (+8%), Surgical $249M (+8%), Pharma $378M (+16%); MIEBO sales $112M in Q4.
- FY2026 guidance: revenue $5.375B-$5.475B (5-7% constant currency growth); adjusted EBITDA ex-IPR&D $1.000B-$1.050B.

## SEC filing metadata
- accession: 0001860742-26-000006
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000186074226000006/0001860742-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000186074226000006/blco-20260218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001860742-26-000006
- JSON: https://secwatch.observer/filing/0001860742-26-000006.json
- Plain text: https://secwatch.observer/filing/0001860742-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.